Company lists · Data refreshed September 2026
Top 25 Oncology drug developers based in Cambridge, United States
RevenueBase identified 58 oncology drug developers headquartered in Cambridge, United States as of September 2026 and tracks 7,588 professional contacts across them, including 2,014 with verified work emails. San Diego is the largest hub.
This list covers oncology drug developers headquartered in Cambridge, United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 20, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest oncology drug developers based in Cambridge, United States
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 2,135 contacts → | ||||
Indirect evidence “Effective March 17, 2025, The U.S.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 2 | 218 contacts → | ||||
Indirect evidence “Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 3 | 137 contacts → | ||||
Partial evidence “iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 4 | 116 contacts → | ||||
Indirect evidence “At Mersana, we have a passion for advancing therapies to make a significant impact in the lives of people living with cancer.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 5 | 81 contacts → | ||||
Partial evidence “Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 6 | 66 contacts → | ||||
Partial evidence “Immuneering is a clinical-stage oncology company focused on keeping cancer patients alive.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 7 | 64 contacts → | ||||
Indirect evidence “Cancer is relentless.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 8 | 47 contacts → | ||||
Indirect evidence “Crossbow Therapeutics, Inc, is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 9 | 43 contacts → | ||||
Indirect evidence “Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 10 | 38 contacts → | ||||
Indirect evidence “Pinetree Therapeutics is an award-winning, pre-clinical stage biotechnology company based in Cambridge, Massachusetts.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 11 | 34 contacts → | ||||
Indirect evidence “Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 12 | 29 contacts → | ||||
Partial evidence “Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 13 | 28 contacts → | ||||
Indirect evidence “Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 14 | 26 contacts → | ||||
Indirect evidence “Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 15 | 23 contacts → | ||||
Indirect evidence “We are Nested Therapeutics, a biotech company inspired by service and driven by a desire to make a meaningful impact.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 16 | 22 contacts → | ||||
Indirect evidence “DEM BioPharma is pioneering the next generation of cancer therapeutics.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 17 | 21 contacts → | ||||
Partial evidence “CancerLinQ brings oncology intelligence drawn directly from care into everyday practice, helping providers measure quality, identify gaps, and understand care patterns using data…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 18 | 20 contacts → | ||||
Indirect evidence “Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 19 | 18 contacts → | ||||
Indirect evidence “Targeting enzymes that control cancer cell state and fitness make cancer cells susceptible to intrinsic and immune-mediated killing but drugging these pathways has been limited by…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 20 | 18 contacts → | ||||
Indirect evidence “GV20 Therapeutics (https://gv20tx.com) was incorporated in 2016 with sites in Cambridge, USA, and Shanghai, China.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 21 | 17 contacts → | ||||
Partial evidence “Predicta Biosciences is a precision oncology company that integrates cutting-edge multiomics and liquid biopsies to create innovative diagnostic and therapeutic products.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 22 | 15 contacts → | ||||
Indirect evidence “Synolo Therapeutics is advancing a new class of therapeutics for cancer.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 23 | 15 contacts → | ||||
Partial evidence “Neon Therapeutics is a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 24 | 8 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 25 | 7 contacts → | ||||
Indirect evidence “SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed - focusing 100% of the effective dose at the right…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: oncology drug developers. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names oncology drug developers.
- Partial evidence
- Its own public description names part of oncology drug developers, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name oncology drug developers. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 58 oncology drug developers based in Cambridge, United States
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 2,014 reachable decision-makers.
Free signup · no credit card
Oncology drug developers based in Cambridge, United States at a glance
As of Sep 20, 2026Companies by employee count
Email recency for this list is measured across the whole United States list rather than for Cambridge, so it is reported there. Company counts and contact totals on this page are exact for Cambridge, over 58 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among oncology drug developers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in Cambridge, United States whose own description of what they do matches “oncology drug developers”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names oncology drug developers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among oncology drug developers, and records with no verified work email. Companies headquartered outside Cambridge are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 2,014 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 20, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Oncology drug developers by metro in the United States
- Oncology drug developers in San Diego70
- Oncology drug developers in Cambridge58
- Oncology drug developers in New York48
- Oncology drug developers in Boston37
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names oncology drug developers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many oncology drug developers are there based in Cambridge, United States?
RevenueBase identified 58 oncology drug developers headquartered in Cambridge, United States as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Beigene, headquartered in Cambridge, tops this list with the largest team on record.
Which city has the most oncology drug developers?
San Diego leads with 70 headquartered companies, followed by Cambridge (58) and New York (48).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 2,014 verified decision-maker contacts tracked across these 58 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 20, 2026.
Ready to reach these companies? Verified emails and direct dials for all 58 oncology drug developers based in Cambridge, United States. Start with a free account, no credit card.
Download this list →Related lists
Oncology drug developers by geography
- Oncology drug developers based in Boston, United States
- Oncology drug developers based in Houston, United States
- Oncology drug developers based in New York, United States
- Oncology drug developers based in San Diego, United States
- Oncology drug developers based in Australia
- Oncology drug developers based in Brazil
- Oncology drug developers based in Canada
- Oncology drug developers based in China
- Oncology drug developers based in France
- Oncology drug developers based in Germany
- Oncology drug developers based in India
- Oncology drug developers based in Italy
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Oncology drug developers based in Boston, United States
- Oncology drug developers based in Houston, United States
- Oncology drug developers based in New York, United States
- Oncology drug developers based in San Diego, United States
- Oncology drug developers based in Australia
- Oncology drug developers based in Brazil